Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Mark Roessel vice president of regulatory affairs and quality assurance and named LuAnn Sabounjian vice president of clinical operations

Allon Therapeutics Inc., of Vancouver, British Columbia, appointed Michael Gold vice president of clinical development and chief medical officer...Jennerex Inc., of San Francisco, appointed James M. Burke vice president of clinical research...Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Amar Singh senior vice president of business and commercial development and named Iman El-Hariry vice president of clinical research

Accera Inc., of Broomfield, Colo., appointed Thomas Werner president and CEO...Advaxis Inc., of North Brunswick, N.J., appointed Robert Petit vice president of clinical operations and medical affairs...AIKO Biotechnology, of Portland, Maine, appointed Jim New CEO and added Paul Goldenheim to its board

Predictive Biosciences Inc., of Lexington, Mass., appointed Thomas M. Ross chief commercial officer and named Randal Vader vice president of clinical and regulatory affairs

Lund most recently was former global vice president of clinical development activities at London-based AstraZeneca plc

PharmaGap Inc., of Ottawa, Ontario, appointed Ken Sokoll vice president of clinical development and chief operating officer

Tengion Inc., of East Norriton, Pa., appointed Sunita B. Sheth chief medical officer and vice president of clinical and regulatory affairs

Chimerix Inc., of Research Triangle Park, N.C., appointed Timothy King vice president of clinical operations and named Herve Mommeja-Marin vice president of clinical research

Ablexis LLC, of San Francisco, appointed Scott Greer chairman and named Richard Hoffman chief business officer...CalciMedica, of La Jolla, Calif., appointed Steven L. Schoenfeld vice president of clinical development

Algeta ASA, of Oslo, Norway, elected Judith Hemberger and Kapil Dhingra to its board of directors...CMDBioscience, of Orange, Conn., appointed Erick Suchanek and Bernhardt Trout to its scientific advisory board...InteKrin Therapeutics Inc., of Los Altos, Calif., appointed Roman Skowronski vice president of clinical development

Idera Pharmaceuticals Inc., of Cambridge, Mass., appointed Robert Arbeit vice president of clinical development and Nicola La Monica vice president of biology, and promoted Timothy Sullivan to vice president of development programs and alliance management

The firm's former president and CEO, Joseph Zakrzewski, will remain on with the company as chairman of the board...Cempra Pharmaceuticals, of Chapel Hill, N.C., named Jennifer Schranz vice president of clinical affairs, Susan R. Moriarty vice president of clinical research, and Elisa Gonzalez and Joe Milata clinical study managers

Tekmira Pharmaceuticals Corp., of Vancouver, British Columbia, appointed Daniel Kisner chairman and named Kenneth Galbraith and Frank Karbe to its board...Topica Pharmaceuticals, of Palo Alto, Calif., appointed Mark W. Davis vice president of clinical development

HistoRx Inc., of New Haven, Conn., named Richard J. Carroll vice president of clinical research...King Pharmaceuticals Inc., of Bristol, Tenn., appointed Kevin S. Crutchfield and Derace Lan Schaffer to its board

Vical Inc., of San Diego, appointed Richard T. Kenney vice president of clinical development

Dynavax Technologies Corp., of Berkeley, Calif., added Brant Biehn as chief commercial development officer and William Heyward as vice president of clinical research

Medivation Inc., of San Francisco, said Chief Financial Officer Patrick Machado will become chief business officer and Karen Reeves will be senior vice president of clinical development

senior vice president of corporate strategy and chief financial officer...Oncothyreon Inc., of Seattle, appointed Diana Hausman vice president of clinical development